Press Releases

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2021:

"I am proud to have introduced H.R. 3617, the 'Marijuana Opportunity Reinvestment and Expungement Act,' or the 'MORE Act,' joined by my colleagues Representatives Barbara Lee, Earl Blumenauer, Nydia Velazquez, Sheila Jackson Lee, and Hakeem Jeffries, as well as many colleagues on this Committee who have signed on as cosponsors.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) issued the following statement after the Committee voted to advance 12 pieces of legislation to the full House of Representatives:

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2116, the Creating a Respectful and Open World for Natural Hair Act of 2021 or the CROWN Act:

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act:

"H.R. 2884, the 'Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act,' is the final bipartisan measure we are considering today to address ever-increasing medical costs and to help make healthcare more affordable.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021:

"H.R. 2873, the 'Affordable Prescriptions for Patients Through Promoting Competition Act of 2021' is bipartisan legislation introduced by Antitrust Subcommittee Chairman Cicilline and Ranking Member Ken Buck to end an anti-competitive practice known as product hopping.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2883, the Stop Stalling Access to Affordable Medications Act:

"Today, one quarter of Americans report that it is difficult to afford their medicines. In fact, exorbitant medical bills are one of the major reasons Americans seek bankruptcy relief.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2891, the Preserve Access to Affordable Generics and Biosimilars Act:

"H.R. 2891, the 'Preserve Access to Affordable Generics and Biosimilars Act,' is a bipartisan bill that I introduced along with Representative Ken Buck to prohibit anti-competitive settlements, also called pay-for-delay agreements, that block access to affordable prescription drugs.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Subcommittee on Courts, Intellectual Property, and the Internet Chairman Hank Johnson (D-GA) issued the following joint statement on the Wall Street Journal's report that over 100 federal judges failed to recuse themselves from lawsuits involving companies in which they or their family held a financial interest: